Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 12, 2020
Surveillance and Monitoring of Hepatocellular Carcinoma During the COVID-19 PandemicNeil Mehta, Neehar D Parikh, R Katie Kelley, et al.Lancet (London, England)|January 31, 2021
Biliary tract cancerJuan W Valle, R Katie Kelley, Bruno Nervi, et al.Drugs|July 4, 2023
New Opportunities to Individualize Frontline Therapy in Advanced Stages of Hepatocellular CarcinomaJohn D Gordan, Bridget P Keenan, Huat Chye Lim, et al.JCO Precision Oncology|June 8, 2022
Clinical, Genomic, and Transcriptomic Data Profiling of Biliary Tract Cancer Reveals Subtype-Specific Immune SignaturesKabir Mody, Prerna Jain, Sherif M El-Refai, et al.Breast Cancer Research and Treatment|February 15, 2016
A phase 1b study of the Akt-inhibitor MK-2206 in combination with weekly paclitaxel and trastuzumab in patients with advanced HER2-amplified solid tumor malignanciesAmy Jo Chien, Alyson Cockerill, Craig Fancourt, et al.Gastrointestinal Cancer Research : GCR|March 19, 2013
Clinicopathologic characteristics and survival outcomes of patients with fibrolamellar carcinoma: data from the fibrolamellar carcinoma consortiumCelina S Ang, R Katie Kelley, Michael A Choti, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 13, 2024
SWOG S1815: A Phase III Randomized Trial of Gemcitabine, Cisplatin, and Nab-Paclitaxel Versus Gemcitabine and Cisplatin in Newly Diagnosed, Advanced Biliary Tract CancersRachna T Shroff, Gentry King, Sarah Colby, et al.JCO Precision Oncology|August 10, 2023
The Cholangiocarcinoma in the Young (CITY) Study: Tumor Biology, Treatment Patterns, and Survival Outcomes in Adolescent Young Adults With CholangiocarcinomaLeontios Pappas, Islam Baiev, Stephanie Reyes, et al.Pageof 1